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Nichols et al. (Lipids Health Dis 13:2, 2014) raised concern about the higher n-6 concentration in fish oil used in our
recent study which is different from typical commercial fish oils (Ramprasath et al. Lipids Health Dis 12:178, 2013).
The aim of our study was to compare the effect of consumption of similar amount of n-3 PUFA from krill and fish
oil with placebo on plasma and RBC fatty acids. As the concentration of n-3 PUFA in the fish oil utilised was higher
than that in krill oil, we deemed it important to keep consistent the concentration of n-3 PUFA and volumes to be
administered to participants between krill versus fish oils. As such, the fish oil used in the study was diluted with corn oil.
Although the n-6 PUFA concentration in fish oil was higher compared to traditionally used fish oil, consumption of the
fish oil used in our study actually reduced the total n-6 PUFA in plasma and RBC to a similar extent as did krill oil. Overall,
our conclusion was that the increases in plasma and RBC concentrations of EPA and DHA along with improvement in
the omega-3 index observed with consumption of krill oil compared with fish oil are due to differences in absorption
and bioavailability based on the structural difference of the two oils rather than their n-6 PUFA content.
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Recently, Ramprasath et al. [1] compared effects of con-
sumption of 600 mg/day of n-3 PUFA from krill or
fish oil versus placebo corn oil by healthy individuals
for 4 weeks separated by 8 week wash out periods
using a double blind randomised cross over study design.
Results showed increased plasma and RBC n-3 PUFA
concentrations after consumption of n-3PUFA from the
krill compared to fish oil. Nichols et al. [2] raised an
issue regarding reported fatty acid profile of fish oil
used in that it possessed high concentrations of n-6 PUFA.
However this assessment did not take into consideration
that the n-3 PUFA concentrations of krill and fish oils
are not similar and hence the concentration of n-3 PUFA
between the two oils needed to be adjusted for consistency.Discussion
Our primary objective was to compare effects of con-
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article, unless otherwise stated.or fish oil. When designing a double blinded placebo
controlled randomised cross over trial, it was felt that
the amounts of treatment products as well as the bioactives
of interest be maintained consistent across different
interventions. However, the n-3 PUFA content of the
krill oil fell below that of fish oil. In order to match the
concentrations of n-3 PUFA and volumes between krill
and fish oil, the fish oil was diluted with the placebo,
corn oil at a ratio of 1.3:1.0. We agree that we could
have included the information about dilution of fish oil
in the original manuscript itself. Addition of corn oil,
to fish oil resulted in higher total n-6 PUFA concentration
in fish oil. We agree that one of the limitations of the
study is not controlling the n-6 fatty acid content between
the different oils, as we mention in the discussion and
study limitations sections of the manuscript [1]. We con-
cede that some influence due to the difference in n-6
PUFA concentration might have occurred. However, we
chose to control only the n-3 PUFA content which is the
most important component of interest in the two oils.
Furthermore, dietary n-6 PUFA consumption by the
participants was not controlled during the study. The
reason to control the n-3 and not the n-6 PUFA was
based on the knowledge we have regarding the typicalntral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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up to 25 times more than n-3 PUFA [3]. Consumption
level of linoleic acid by an American adult approaches
17 grams per day on average for males and 13 grams per
day for females [4]. Thus, variations in amounts of n-6
PUFA in the diet are foreseeably greater than the difference
in their amounts between the different treatment oils. It is
relevant to point out that fish oil reduced the total n-6
PUFA in plasma as well as RBC to similar extent as
krill oil despite having a higher n-6 PUFA content in
the fish oil [1]. Accordingly, we suggest that increased
plasma and RBC n-3 PUFA concentrations with krill oil
consumption compared with fish oil might be due to
differences in absorption and bioavailability based on
the structural difference of the two oils rather than their
n-6 PUFA content.
Plasma linoleic acid levels were significantly decreased
after both krill and fish oil consumption compared with
placebo. However, no significant difference in the plasma
end point concentration was observed for linoleic acid
between krill and fish oils. Furthermore, no changes in
linoleic acid concentrations within RBCs were seen with
any of the oil treatments [1]. Hence, although a difference
existed in the n-6 PUFA concentration and ratio between
n-6 and n-3 PUFA between krill and fish oils, their effects
on the plasma and RBC n-6 PUFA and linoleic acids were
shown to be almost identical. It has also been previously
shown that a half dose of krill oil has a similar effect as
a single dose of fish oil on increasing plasma n-3 PUFA
concentrations [5].
Another comment Nichols et al. raised was regarding
variations in the levels of n-3 PUFA in the fish and krill
oil supplements (Table 1 in the original manuscript) [2].
Nichols and colleagues might have made an erroneous
assumption when they calculated the percent of fatty acids
as percent of the entire oil. As indicated (Table 6 in the
original manuscript) [1], the amount of fatty acids is
given as percent of total fatty acids, not of the total oil.
Thus, the amount of n-3 PUFA consumed from both
krill and fish oil was 600 mg per day in our study [1].
Conclusion
In summary, although, the n-6 PUFA concentration in fish
oil used in the study was higher than that of the krill oil,
the effect of consumption of these two oils resulted in
similar perturbations on the plasma n-6 PUFA concentra-
tions. As such, the greater increase in concentrations of
EPA and DHA in plasma and RBC along with improve-
ment in the omega-3 index following krill oil compared
with fish oil consumption is due to increased bioavailability
of n-3 PUFA from krill oil than fish oil.
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